logo

ABEO

Abeona Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.60 / 10
Netural

Analyst coverage is limited to one source, but it is strongly bullish (100% Strong Buy). Money-flow analysis shows a 7.92/10 score with positive Large-block flows, hinting at some institutional accumulation. However, overall fund trends are negative, and the mismatch between bullish analyst ratings and weak price action underscores uncertainty. Investors should interpret the analyst stance cautiously given its historical win-rate of only 40%.

FundamentalSentiment(5.6)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-10-13
InstitutionHC Wainwright & Co.
Times predicted5
Historical Win Rate40.0%
Is money flowing into or out of ABEO?
  • ABEO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.60/10 (Netural).